|Articles|March 15, 2003

FDA seeks innovation, shorter review process

Washington, DC-The FDA is proposing a set of guidelines geared toward improving the development and availability of new drugs and medical devices.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.


Latest CME